Individualized closed-loop TMS synchronized with exoskeleton for modulation of cortical-excitability in patients with stroke: a proof-of-concept study

被引:0
|
作者
Singh, Neha [1 ]
Saini, Megha [1 ]
Kumar, Nand [2 ]
Padma Srivastava, M. V. [3 ]
Mehndiratta, Amit [1 ,4 ]
机构
[1] Indian Inst Technol, Ctr Biomed Engn, New Delhi, India
[2] All India Inst Med Sci AIIMS, Dept Psychiat, New Delhi, India
[3] AIIMS, Dept Neurol, New Delhi, India
[4] AIIMS, Dept Biomed Engn, New Delhi, India
关键词
stroke; transcranial magnetic stimulation; exoskeleton; closed-loop brain stimulation; neuro-rehabilitation; motor evoked potential; spasticity; TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX; HAND; PLASTICITY; RESPONSES; RECOVERY; THERAPY; MEMORY;
D O I
10.3389/fnins.2023.1116273
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Repetitive TMS is used in stroke rehabilitation with predefined passive low and high-frequency stimulation. Brain State-Dependent Stimulation (BSDS)/Activity-Dependent Stimulation (ADS) using bio-signal has been observed to strengthen synaptic connections. Without the personalization of brain-stimulation protocols, we risk a one-size-fits-all approach. Methods: We attempted to close the ADS loop via intrinsic-proprioceptive (via exoskeleton-movement) and extrinsic-visual-feedback to the brain. We developed a patient-specific brain stimulation platform with a two-way feedback system, to synchronize single-pulse TMS with exoskeleton along with adaptive performance visual feedback, in real-time, for a focused neurorehabilitation strategy to voluntarily engage the patient in the brain stimulation process. Results: The novel TMS Synchronized Exoskeleton Feedback (TSEF) platform, controlled by the patient's residual Electromyogram, simultaneously triggered exoskeleton movement and single-pulse TMS, once in 10 s, implying 0.Hz frequency. The TSEF platform was tested for a demonstration on three patients (n=3) with different spasticity on the Modified Ashworth Scale (MAS=1, 1+, 2) for one session each. Three patients completed their session in their own timing; patients with (more) spasticity tend to take (more) inter-trial intervals. A proof-of-concept study on two groups-TSEF-group and a physiotherapy control-group was performed for 45min/day for 20-sessions. Dose-matched Physiotherapy was given to control-group. Post 20 sessions, an increase in ipsilesional cortical-excitability was observed; Motor Evoked Potential increased by similar to 48.5 mu V at a decreased Resting Motor Threshold by similar to 15.6%, with improvement in clinical scales relevant to the Fugl-Mayer Wrist/Hand joint (involved in training) by 2.6 units, an effect not found in control-group. This strategy could voluntarily engage the patient. Conclusion: A brain stimulation platform with a real-time two-way feedback system was developed to voluntarily engage the patients during the brain stimulation process and a proof-of-concept study on three patients indicates clinical gains with increased cortical excitability, an effect not observed in the control-group; and the encouraging results nudge for further investigations on a larger cohort.
引用
收藏
页数:11
相关论文
共 41 条
  • [31] Closed-loop transcutaneous auricular vagus nerve stimulation for the improvement of upper extremity motor function in stroke patients: a study protocol
    Xiao, Xue-Zhen
    Li, Rongdong
    Xu, Chengwei
    Liang, Siqi
    Yang, Meng
    Zhong, Haili
    Huang, Xiyan
    Ma, Jingjing
    Xie, Qiuyou
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [32] Modulation of hyperacusis and tinnitus loudness in tinnitus patients with and without hearing loss following 3 weeks of acoustic stimulation: A proof-of-concept study
    Fournier, Philippe
    Bigras, Charlotte
    Lehmann, Alexandre
    Norena, Arnaud J.
    Hebert, Sylvie
    TINNITUS - AN INTERDISCIPLINARY APPROACH TOWARDS INDIVIDUALIZED TREATMENT: TOWARDS UNDERSTANDING THE COMPLEXITY OF TINNITUS, 2021, 262 : 57 - 91
  • [33] Use of electromyography to optimize Lokomat® settings for subject-specific gait rehabilitation in post-stroke hemiparetic patients: A proof-of-concept study
    Cherni, Yosra
    Begon, Mickael
    Chababe, Hicham
    Moissenet, Florent
    NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2017, 47 (04): : 293 - 299
  • [34] Influence of ketamine and morphine on descending pain modulation in chronic pain patients: a randomized placebo-controlled cross-over proof-of-concept study
    Niesters, M.
    Aarts, L.
    Sarton, E.
    Dahan, A.
    BRITISH JOURNAL OF ANAESTHESIA, 2013, 110 (06) : 1010 - 1016
  • [35] Development of an automated closed-loop β-blocker delivery system to stably reduce myocardial oxygen consumption without inducing circulatory collapse in a canine heart failure model: a proof of concept study
    Nishikawa, Takuya
    Uemura, Kazunori
    Hayama, Yohsuke
    Kawada, Toru
    Saku, Keita
    Sugimachi, Masaru
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 2022, 36 (03) : 849 - 860
  • [36] Development of an automated closed-loop β-blocker delivery system to stably reduce myocardial oxygen consumption without inducing circulatory collapse in a canine heart failure model: a proof of concept study
    Takuya Nishikawa
    Kazunori Uemura
    Yohsuke Hayama
    Toru Kawada
    Keita Saku
    Masaru Sugimachi
    Journal of Clinical Monitoring and Computing, 2022, 36 : 849 - 860
  • [37] A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
    T. Vanassche
    M. M. Engelen
    Q. Van Thillo
    J. Wauters
    J. Gunst
    C. Wouters
    C. Vandenbriele
    S. Rex
    L. Liesenborghs
    A. Wilmer
    P. Meersseman
    G. Van den Berghe
    D. Dauwe
    G. Verbeke
    M. Thomeer
    T. Fivez
    D. Mesotten
    D. Ruttens
    L. Heytens
    I. Dapper
    S. Tuyls
    B. De Tavernier
    P. Verhamme
    Trials, 21
  • [38] A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
    Vanassche, T.
    Engelen, M. M.
    Van Thillo, Q.
    Wauters, J.
    Gunst, J.
    Wouters, C.
    Vandenbriele, C.
    Rex, S.
    Liesenborghs, L.
    Wilmer, A.
    Meersseman, P.
    Van den Berghe, G.
    Dauwe, D.
    Verbeke, G.
    Thomeer, M.
    Fivez, T.
    Mesotten, D.
    Ruttens, D.
    Heytens, L.
    Dapper, I
    Tuyls, S.
    De Tavernier, B.
    Verhamme, P.
    TRIALS, 2020, 21 (01)
  • [39] Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
    T. Vanassche
    M. M. Engelen
    Q. Van Thillo
    J. Wauters
    J. Gunst
    C. Wouters
    C. Vandenbriele
    S. Rex
    L. Liesenborghs
    A. Wilmer
    P. Meersseman
    G. Van den Berghe
    D. Dauwe
    G. Verbeke
    M. Thomeer
    T. Fivez
    D. Mesotten
    D. Ruttens
    L. Heytens
    I. Dapper
    S. Tuyls
    B. De Tavernier
    P. Verhamme
    Trials, 21
  • [40] Study protocol: a randomised controlled proof-of-concept real-world study - does maximising time in range using hybrid closed loop insulin delivery and a low carbohydrate diet restore the glucagon response to hypoglycaemia in adults with type 1 diabetes?
    Baxter, Faye
    Baillie, Nicola
    Forbes, Shareen
    BMJ OPEN, 2022, 12 (12):